The Gonorrhea Therapeutics Market is witnessing steady growth due to the increasing prevalence of sexually transmitted infections (STIs), growing awareness regarding early diagnosis and treatment, and continuous advancements in antimicrobial therapies. Gonorrhea, caused by the bacterium Neisseria gonorrhoeae, remains one of the most common sexually transmitted infections worldwide. The disease...